Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

Balchem: 3 Key Takeaways for Long-Term Investors

Source The Motley Fool

Key Points

Third-quarter net sales rose 8.6% year over year to $291 million.
Human nutrition and health segment sales increased 8.1% to $188 million.
Animal nutrition and health operating earnings rose 82.8% to $6.8 million.
10 stocks we like better than Balchem ›

On its third quarter of 2026 earnings call, held on Oct. 23, 2026, Balchem (NASDAQ:BCPC) announced record quarterly consolidated sales of $291 million. The company continues to expand profit margins by shifting toward high-value nutrient technologies. Consistent cash generation supports reinvestment in innovation while keeping debt low. Three takeaways from the call stand out.

1. Clinical Trials Expand Specialty Ingredients Into Adult Health

Balchem is expanding its science-backed ingredients, including VitaCholine brand choline and K2VITAL DELTA brand vitamin K2, from infant nutrition into adult cognitive and cardiovascular markets. Clinical validation builds pricing power and customer trust in high-margin specialty markets.

The findings provide encouraging new evidence that may support the role of VitaCholine in lifelong brain health and further strengthen the scientific foundation of choline in healthy aging and cognition.
-- Theodore L. Harris, Chairman, President, and Chief Executive Officer

2. Proprietary Tech Drives Adoption in Animal Nutrition

Farmer adoption of encapsulated nutrient technology improves herd efficiency and protects sales from broader market swings. International expansion and new product launches further extend this advantage.

Market penetration is still one where even if the market were not to grow, we can still drive growth through penetration and adoption of our technologies
-- Carl Martin Bengtsson, Chief Financial Officer

3. High-Margin Product Mix Fuels Segment Profitability

Faster sales growth in premium human and animal nutrients relative to standard products creates a natural margin boost. Passing through higher input costs protects cash flow while product mix expands profitability.

So there are tailwinds within both of those segments. And, obviously, with our specialty products segment having grown nicely, being very high margin as well for us as a business, it just supports a nice tailwind for us.
-- Carl Martin Bengtsson, Chief Financial Officer

Looking Ahead

Fourth-quarter operations face typical seasonal slowdowns, but demand trends stay intact. Proprietary technology and a credit facility position Balchem to expand capacity, while leadership prioritizes supply chain security.

As we look ahead to the fourth quarter, we are optimistic about the outlook.
-- Carl Martin Bengtsson, Chief Financial Officer

Organic sales gains and steady capital allocation reinforce long-term stability across shifting economic cycles.

The third quarter marked our 29th consecutive quarter of year over year growth in adjusted EBITDA. That level of consistency across a wide range of market conditions reflects the strength of our unique portfolio, the resilience of our business model, and the dedication of our team.
-- Theodore L. Harris, Chairman, President, and Chief Executive Officer

Should you buy stock in Balchem right now?

Before you buy stock in Balchem, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Balchem wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $361,596!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,303,935!*

Now, it’s worth noting Stock Advisor’s total average return is 910% — a market-crushing outperformance compared to 211% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of October 23, 2026.

The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Dollar presses 102 as the 10-year yield sits at 5.14% — and October hike odds are only 17%The dollar index closed at 101.99 (+0.20%) on Monday after briefly topping 102.07, while the 10-year Treasury yield rose to 5.14% and the 2-year hit 4.774% — yet futures price only about a 17% chance of a hike at the October 27-28 FOMC, versus roughly 90% for December. The driver is a global bond selloff, not a Fed repricing: France's 10-year OAT jumped to 4.84% ~ 4.94% and the OAT-Bund spread widened to 140 ~ 146bp. Here are the levels, the cross-asset read-through and what to watch.

Author Irene Q.

Oct 20, Tue

The dollar index closed at 101.99 (+0.20%) on Monday after briefly topping 102.07, while the 10-year Treasury yield rose to 5.14% and the 2-year hit 4.774% — yet futures price only about a 17% chance of a hike at the October 27-28 FOMC, versus roughly 90% for December. The driver is a global bond selloff, not a Fed repricing: France's 10-year OAT jumped to 4.84% ~ 4.94% and the OAT-Bund spread widened to 140 ~ 146bp. Here are the levels, the cross-asset read-through and what to watch.

Meta's AI bill just hit $145 billion — and it issued a new share class to pay for it Meta reported record third-quarter revenue of $64.60 billion, up 26% from a year earlier, and raised full-year 2026 capital expenditure guidance to $135-145 billion from $130-145 billion. To fund that build-out without touching Mark Zuckerberg's voting control, the company announced a 2-for-1 stock split that hands every Class A holder a new non-voting Class C share. Here are the four lines that matter, the peer group that is being re-rated alongside it, and the bull and bear cases.

Author Irene Q.

Oct 22, Thu

Meta reported record third-quarter revenue of $64.60 billion, up 26% from a year earlier, and raised full-year 2026 capital expenditure guidance to $135-145 billion from $130-145 billion. To fund that build-out without touching Mark Zuckerberg's voting control, the company announced a 2-for-1 stock split that hands every Class A holder a new non-voting Class C share. Here are the four lines that matter, the peer group that is being re-rated alongside it, and the bull and bear cases.

The Fed will sit still on October 28 — but 100 of 100 economists now expect a December hike A Reuters poll run October 16-20 found 94 of 100 economists expecting the Fed to hold at 3.75-4.00% on October 28 — and all 100 expecting a hike in December, against less than half a month earlier. The market is close to the same price, with CME FedWatch at roughly 17% for October and 82.8% for December. With the Fed in blackout since October 17, here are the five dates that decide the rest of the year, what each one is priced for, and the two directions each can take.

Author Irene Q.

Oct 22, Thu

A Reuters poll run October 16-20 found 94 of 100 economists expecting the Fed to hold at 3.75-4.00% on October 28 — and all 100 expecting a hike in December, against less than half a month earlier. The market is close to the same price, with CME FedWatch at roughly 17% for October and 82.8% for December. With the Fed in blackout since October 17, here are the five dates that decide the rest of the year, what each one is priced for, and the two directions each can take.

Gold Price Analysis Today | Forex Gold Analysis | XAU/USD Analysis - October 23, 2026 Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for October 23, 2026. Read on for the details.

Author Mitrade

Yesterday 02: 56

Get the latest gold price analysis, forex gold insights, and XAU/USD analysis for October 23, 2026. Read on for the details.

Nasdaq closes at 26,008.86 — 8.9 points above 26,000, and the credit market never blinked The Nasdaq Composite fell 2.60% to 26,008.86 on October 22, its worst session since June, as Meta sank 6.98% on 2026 capex guidance of $135–145 billion. But the equal-weight S&P 500 rose 0.73%, high-yield credit was flat and 10-year yields fell 20 basis points. This was an AI de-rating, not a risk-off event — here is the transmission chain, the 29,000 / 28,200 levels and what would prove it wrong.

Author Irene Q.

Yesterday 06: 39

The Nasdaq Composite fell 2.60% to 26,008.86 on October 22, its worst session since June, as Meta sank 6.98% on 2026 capex guidance of $135–145 billion. But the equal-weight S&P 500 rose 0.73%, high-yield credit was flat and 10-year yields fell 20 basis points. This was an AI de-rating, not a risk-off event — here is the transmission chain, the 29,000 / 28,200 levels and what would prove it wrong.

Popular Symbols